lenacapavir yeztugo - Search News

News

HIV prevention drug lenacapavir approved by FDA

6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.

CBS News on MSN · 1d

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

Wired · 11h

The FDA Just Approved a Long-Lasting Injection to Prevent HIV

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.

Everyday Health on MSN2h

FDA Approves a ‘Game-Changing’ Twice-a-Year HIV Prevention Shot

The new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or every-other-month injections.

11h

BMO says lenacapavir approval for prevention a ‘major win’ for Gilead

Although largely as expected by investors, BMO Capital says lenacapavir’s approval for prevention, now known as Yeztugo, marks “a major win for Gilead (GILD)” in driving meaningful growth in its ...

Managed Healthcare Executive22h

With Lenacapavir 'You've Basically Got a Vaccine.' But Reaching the People Who Would Benefit Is Difficult, Says Gates Foundation Expert

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results